134 related articles for article (PubMed ID: 36136898)
21. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H
Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783
[TBL] [Abstract][Full Text] [Related]
22. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
23. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
[TBL] [Abstract][Full Text] [Related]
24. A case report of papillary thyroid carcinoma dedifferentiated to squamous cell carcinoma presenting as a lung metastasis: A potential diagnostic pitfall.
Gadde R; Tafe LJ; Tsapakos MJ; Liu X
Diagn Cytopathol; 2020 Jun; 48(6):581-585. PubMed ID: 32271487
[TBL] [Abstract][Full Text] [Related]
25. The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung.
Galindo I; Gómez-Morales M; Díaz-Cano I; Andrades Á; Caba-Molina M; Miranda-León MT; Medina PP; Martín-Padron J; Fárez-Vidal ME
Ups J Med Sci; 2020 Feb; 125(1):19-29. PubMed ID: 31809668
[No Abstract] [Full Text] [Related]
26. Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling.
Yousem SA
Hum Pathol; 2009 Jun; 40(6):861-7. PubMed ID: 19269005
[TBL] [Abstract][Full Text] [Related]
27. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
[TBL] [Abstract][Full Text] [Related]
28. Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinoma.
Smits AJ; Vink A; Tolenaars G; Herder GJ; Kummer JA
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):416-21. PubMed ID: 25356948
[TBL] [Abstract][Full Text] [Related]
29. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance and accuracy of p63 and TTF-1 for better approach of small cell lung carcinoma versus poorly differentiated nonkeratinizing squamous cell carcinoma.
Gurguş D; Grigoraş ML; Motoc AGM; Zamfir CL; Cornianu M; Faur CI; Pop DL; Folescu R
Rom J Morphol Embryol; 2019; 60(1):139-143. PubMed ID: 31263838
[TBL] [Abstract][Full Text] [Related]
31. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
32. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
[TBL] [Abstract][Full Text] [Related]
33. Role of immunohistochemistry markers in neoplastic lung lesions.
Umakanthan S; Chalapathi Rao AV; Mohammed W
J Cancer Res Ther; 2021; 17(6):1382-1388. PubMed ID: 34916368
[TBL] [Abstract][Full Text] [Related]
34. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
Masai K; Tsuta K; Kawago M; Tatsumori T; Kinno T; Taniyama T; Yoshida A; Asamura H; Tsuda H
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):292-7. PubMed ID: 23060301
[TBL] [Abstract][Full Text] [Related]
35. Endobronchial Pagetoid Spread of a Breast Carcinoma Metastatic to the Lung.
Monica MA; Baccarini P; Cucchi MC; Lacava N; Foschini MP
Int J Surg Pathol; 2017 Feb; 25(1):83-86. PubMed ID: 27435300
[TBL] [Abstract][Full Text] [Related]
36. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
37. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
38. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
39. p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Nobre AR; Albergaria A; Schmitt F
Acta Cytol; 2013; 57(1):1-8. PubMed ID: 23221041
[TBL] [Abstract][Full Text] [Related]
40. Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas.
Briski LM; Aron M; Epstein JI; Russell DH; Assarzadegan N; Delma KS; O'Dell H; Rodriguez E; Montgomery EA; Kryvenko ON
Int J Surg Pathol; 2024 Apr; 32(2):230-238. PubMed ID: 37170625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]